Biology Reference
In-Depth Information
Xu RX, Hassell AM, Vanderwall D, Lambert MH, Holmes WD, Luther MA, Rocque WJ,
Milburn MV, Zhao Y, Ke H, Nolte RT (2000) Atomic structure of PDE4: insights into
phosphodiesterase mechanism and specificity. Science 288:1822-1825
Yarwood SJ, Steele MR, Scotland G, Houslay MD, Bolger GB (1999) The RACK1 signaling
scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5
isoform. J Biol Chem 274:14909-14917
Zeller E, Stief HJ, Pflug B, Sastre-y-Hernandez M (1984) Results of a phase II study of the
antidepressant effect of rolipram. Pharmacopsychiatry 17:188-190
Zhang KY, Card GL, Suzuki Y, Artis DR, Fong D, Gillette S, Hsieh D, Neiman J, West BL,
Zhang C, Milburn MV, Kim SH, Schlessinger J, Bollag G (2004) A glutamine switch
mechanism for nucleotide selectivity by phosphodiesterases. Mol Cell 15:279-286
Zhang HT, Zhao Y, Huang Y, Deng C, Hopper AT, De Vivo M, Rose GM, O'Donnell JM (2006)
Antidepressant-like effects of PDE4 inhibitors mediated by the high-affinity rolipram binding
state (HARBS) of the phosphodiesterase-4 enzyme (PDE4) in rats. Psychopharmacology
(Berl) 186:209-217
Zhao Y, Zhang HT, O'Donnell JM (2003) Inhibitor binding to type 4 phosphodiesterase (PDE4)
assessed using [3 H]piclamilast and [3 H]rolipram. J Pharmacol Exp Ther 305:565-572
